Visiogen Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$400M
Visiogen General Information
Description
Developer of products for cataract and refractive patients. The company offers an accommodating intraocular lens, which provides distance, intermediate, and near vision to presbyopic cataract patients.
Contact Information
Corporate Office
- Two Goodyear
- Suite B
- Irvine, CA 92618
- United States
Corporate Office
- Two Goodyear
- Suite B
- Irvine, CA 92618
- United States
Visiogen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 20-Oct-2009 | $400M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series E) | 27-Apr-2009 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 28-Feb-2007 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C2) | 03-Feb-2005 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 02-Dec-2003 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B2) | 25-Jun-2002 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B1) | 21-Jun-2001 | $4.09M | $4.39M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | $300K | $300K | Completed |
Visiogen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C2 | ||||||||
| Series C | ||||||||
| Series B2 | ||||||||
| Series B1 | 3,407,036 | $0.000100 | $0.1 | $1.2 | $1.2 | 1x | $1.2 | 7.69% |
| Series A | 1,000,000 | $0.000100 | $0.02 | $0.3 | $0.3 | 1x | $0.3 | 2.26% |
Visiogen Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DLJ Capital Group | Venture Capital | Minority | ||
| Foundation Medical Partners | Corporate Venture Capital | Minority | ||
| New Leaf Venture | Venture Capital | Minority | ||
| Novartis Venture Fund | Corporate Venture Capital | Minority | ||
| Pinnacle Ventures | Venture Capital | Minority |
Visiogen FAQs
-
When was Visiogen founded?
Visiogen was founded in 2001.
-
Where is Visiogen headquartered?
Visiogen is headquartered in Irvine, CA.
-
What industry is Visiogen in?
Visiogen’s primary industry is Therapeutic Devices.
-
Is Visiogen a private or public company?
Visiogen is a Private company.
-
What is the current valuation of Visiogen?
The current valuation of Visiogen is .
-
What is Visiogen’s current revenue?
The current revenue for Visiogen is .
-
How much funding has Visiogen raised over time?
Visiogen has raised $90.1M.
-
Who are Visiogen’s investors?
DLJ Capital Group, Foundation Medical Partners, New Leaf Venture, Novartis Venture Fund, and Pinnacle Ventures are 5 of 10 investors who have invested in Visiogen.
-
When was Visiogen acquired?
Visiogen was acquired on 20-Oct-2009.
-
Who acquired Visiogen?
Visiogen was acquired by Abbott.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process